← All stocks

GeneDx Holdings Corp.

WGS Net buying
CIK 0001818331 #1896 in the set updated 21 Sep 2026
Bought (120 mo)
$305.78M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$240.05M
$19.30M on a plan · $31.36M straight out of an exercise
Sold at will
$189.40M
183 of 386 sales
Net
+$65.73M
+$116.38M against sales at will

By person

27 insiders · 457 transactions
15.9×

Katherine Stueland holds 15.9 times base salary in stock. $11.43M of shares against $715.87K in salary for 2025.

Salary from the company's own proxy. The shares are what Katherine Stueland last reported holding, valued at $99.00, the price Class A Common Stock was last bought or sold at on the open market here, on 16 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Meister Keith A.
Director
$128.39M (35)
$3.85M (2)
+$124.54M
4,808,275
16.12%
$476.00M
Casdin Eli
Director
$75.75M (3)
+$75.75M
30,303,586
$3.00B
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
10% owner
$35.00M (2)
$75.33M (3)
−$40.33M
2,719,692
9.12%
$269.24M
Stueland Katherine
CHIEF EXECUTIVE OFFICER
$100.00K (1)
$39.36M (123) scheduled
−$39.26M
115,476
0.3872%
$11.43M
−49.3%
OPKO HEALTH, INC. entity
10% owner
$5.00M (1)
$29.70M (19)
−$24.70M
2,646,972
8.88%
$262.04M
Casdin Capital, LLC entity
Director
$41.12M (14)
$60.45M (1)
−$19.33M
7,214,328
24.19%
$714.18M
+16.9%
Feeley Kevin
CHIEF FINANCIAL OFFICER
$14.48M (122) scheduled
−$14.48M
44,945
0.1507%
$4.45M
Blackstone Tactical Opportunities Associates III - NQ L.P. entity
10% owner
$10.00M (3)
+$10.00M
162,309
0.5442%
$16.07M
BTO Sema4 Holdings L.P. entity
10% owner
$10.00M (3)
+$10.00M
162,309
0.5442%
$16.07M
Ryan Jason
Director
$161.37K (2)
$8.33M (16)
−$8.17M
118,764
0.3982%
$11.76M
+282.0%
RUCH JOSHUA
Director
$6.09M (15)
−$6.09M
153,382
0.5143%
$15.18M
Dechairo Bryan
Chief Operating Officer
$850.56K (12) scheduled
−$850.56K
0
0.0000%
$0.00
Ro Isaac
Former CFO
$727.24K (8) scheduled
−$727.24K
244,041
0.8183%
$24.16M
Saad Kareem
CHIEF TRANSFORMATION OFFICER
$259.50K (27)
−$259.50K
29,517
0.0990%
$2.92M
Schadt Eric
President & Chief R&D Officer
$192.48K (1)
$412.26K (3) scheduled
−$219.78K
243,380
0.8161%
$24.09M
PFENNIGER RICHARD C JR
Director
$69.91K (3)
+$69.91K
45,082
0.1512%
$4.46M
White Karen Ann
Chief People Officer
$57.27K (17)
−$57.27K
4,761
0.0160%
$471.32K
Assad Shawn
Former CAO
$52.10K (5)
−$52.10K
43,040
0.1443%
$4.26M
+4,303,900%
Coffin James
President and COO
$43.37K (1) scheduled
−$43.37K
22,903
0.0768%
$2.27M
Prentice Anthony
Former Chief Product Officer
$27.44K (5)
−$27.44K
12,102
0.0406%
$1.20M
Clark Daniel Emmett
Former Secretary and GC
$19.88K (5)
−$19.88K
312,207
1.05%
$30.91M
+1,445%
Miao Richard
Former Interim CFO
$7.06K (2)
−$7.06K
24,867
0.0834%
$2.46M
+43.0%
Sherman Rachel E.
Director
58,290
0.1955%
$5.77M
Turner Nat
Director
37,836
0.1269%
$3.75M
Leproust Emily M.
Director
24,852
0.0833%
$2.46M
Pellini Michael J
Director
17,114
0.0574%
$1.69M
Fuchs Thomas
Director
1,146
0.0038%
$113.45K
Insider
Date
Role
Action
Shares
Price
Amount
RUCH JOSHUA
5 Feb 2025
Director
Exercised, kept
5,816
$7.89
$45.89K
RUCH JOSHUA
17 Jan 2025
Director
Exercised, kept
3,000
$7.89
$23.67K
Showing 250 of 457 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 389
Amendments (4/A) skipped 14
Filings about a different issuer 0
Unreadable filings 0
Joint filings 24
Sales on a Rule 10b5-1 plan 64
Sales straight out of an exercise 139
Sales at will 183
Transactions with no price 0
Shares from compensation/vesting 150,817,325
Sales filed before the plan box existed 38
History held since 26 Jul 2021